SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 11.68 |
Enterprise Value ($M) | -8.31 |
Book Value ($M) | 20.01 |
Book Value / Share | 5.33 |
Price / Book | 0.58 |
NCAV ($M) | 4.47 |
NCAV / Share | 1.19 |
Price / NCAV | 2.62 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.07 |
Return on Assets (ROA) | -0.63 |
Return on Equity (ROE) | -1.28 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.05 |
Current Ratio | 3.46 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 28.22 |
Assets | 43.77 |
Liabilities | 23.75 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Goodwood Inc. | 8.20 | 16.11 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
17,813 | 56,818 | 31.35 | |
23,950 | 154,588 | 15.49 | |
2,580 | 3,431 | 75.20 | |
315 | 902 | 34.92 | |
3,435 | 11,795 | 29.12 | |
(click for more detail) |
Similar Companies | |
---|---|
CRIS – Curis, Inc. | CRVO – CervoMed Inc. |
CSBR – Champions Oncology, Inc. | CTXR – Citius Pharmaceuticals, Inc. |
CUE – Cue Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io